Published in Cancer on May 15, 2004
Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79
Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev (2011) 2.62
Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ (2007) 2.60
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) (2009) 2.46
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev (2009) 2.10
Five misconceptions in cancer diagnosis. Br J Gen Pract (2009) 2.07
Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med (2010) 1.98
Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States. Am J Med (2010) 1.90
The influence of health literacy on colorectal cancer screening knowledge, beliefs and behavior. J Natl Med Assoc (2007) 1.79
Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Cancer Epidemiol Biomarkers Prev (2008) 1.77
Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Br J Cancer (2011) 1.75
Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer (2007) 1.75
The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med (2010) 1.68
A multilevel intervention to promote colorectal cancer screening among community health center patients: results of a pilot study. BMC Fam Pract (2009) 1.67
Barriers to colorectal cancer screening in community health centers: a qualitative study. BMC Fam Pract (2008) 1.63
Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health (2006) 1.62
Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population. Am J Prev Med (2011) 1.51
Automated telephone calls improved completion of fecal occult blood testing. Med Care (2010) 1.50
Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. BMC Med Inform Decis Mak (2005) 1.50
Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev Chronic Dis (2006) 1.48
Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health (2006) 1.48
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med (2010) 1.47
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med (2010) 1.42
Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer (2008) 1.42
Colorectal cancer screening among underserved Korean Americans in Los Angeles County. J Immigr Minor Health (2008) 1.39
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
Urban-rural disparities in colorectal cancer screening: cross-sectional analysis of 1998-2005 data from the Centers for Disease Control's Behavioral Risk Factor Surveillance Study. Cancer Med (2012) 1.33
Shared decision-making--transferring research into practice: the Analytic Hierarchy Process (AHP). Patient Educ Couns (2008) 1.33
Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31
Colorectal cancer screening among low-income African Americans in East Harlem: a theoretical approach to understanding barriers and promoters to screening. J Urban Health (2007) 1.29
Socioeconomic position and participation in colorectal cancer screening. Br J Cancer (2010) 1.28
Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med (2010) 1.27
Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc (2007) 1.27
As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther (2008) 1.25
Racism and health inequity among Americans. J Natl Med Assoc (2006) 1.25
Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterol (2007) 1.24
Increasing colon cancer testing in rural Colorado: evaluation of the exposure to a community-based awareness campaign. BMC Public Health (2009) 1.23
Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med (2010) 1.23
Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med (2013) 1.22
Colorectal cancer screening in 3 racial groups. Am J Health Behav (2007) 1.21
Geographic variation and effect of area-level poverty rate on colorectal cancer screening. BMC Public Health (2008) 1.18
Colorectal cancer prevention for low-income, sociodemographically-diverse adults in public housing: baseline findings of a randomized controlled trial. BMC Public Health (2009) 1.16
Higher physician density is associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med (2010) 1.15
Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis. Int J Health Geogr (2010) 1.15
Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status. Health Serv Res (2006) 1.13
Colonoscopy screening in African Americans and Whites with affected first-degree relatives. Arch Intern Med (2008) 1.13
Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med (2010) 1.12
Colorectal cancer test use among Californians of Mexican origin: influence of language barriers. Ethn Dis (2009) 1.11
Having a personal health care provider and receipt of colorectal cancer testing. Ann Fam Med (2009) 1.10
Narratives that address affective forecasting errors reduce perceived barriers to colorectal cancer screening. Soc Sci Med (2010) 1.10
Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening. Am J Public Health (2013) 1.10
Race moderates the relationship between obesity and colorectal cancer screening in women. Cancer Causes Control (2009) 1.09
Why are Korean American physicians reluctant to recommend colorectal cancer screening to Korean American patients? Exploratory interview findings. J Immigr Minor Health (2008) 1.07
Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation. Br J Cancer (2012) 1.07
Overcoming poor attendance to first scheduled colonoscopy: a randomized trial of peer coach or brochure support. J Gen Intern Med (2007) 1.06
Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy. World J Gastroenterol (2011) 1.06
Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care (2012) 1.05
Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs. Prev Chronic Dis (2008) 1.05
Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol (2011) 1.04
Factors associated with colon cancer stage at diagnosis. Dig Dis Sci (2009) 1.04
Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women's Health Initiative observational cohort. J Womens Health (Larchmt) (2008) 1.04
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol (2010) 1.03
Reducing inequities in colorectal cancer screening in North America. J Carcinog (2014) 1.00
FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit. J Rural Health (2012) 0.98
Low uptake of colorectal cancer screening among African Americans in an integrated Veterans Affairs health care network. Gastrointest Endosc (2014) 0.98
Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract (2012) 0.98
Predictors of CT colonography utilization among asymptomatic medicare beneficiaries. J Gen Intern Med (2013) 0.97
Impact of a generalizable reminder system on colorectal cancer screening in diverse primary care practices: a report from the prompting and reminding at encounters for prevention project. Med Care (2008) 0.97
Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res (2011) 0.96
Sociocultural differences and colorectal cancer screening among African American men and women. Oncol Nurs Forum (2012) 0.96
Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer (2013) 0.96
Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]. BMC Public Health (2005) 0.96
Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults. Prev Med (2014) 0.95
What would make getting colorectal cancer screening easier? Perspectives from screeners and nonscreeners. Gastroenterol Res Pract (2012) 0.95
Colorectal cancer disparities: issues, controversies and solutions. World J Gastroenterol (2014) 0.95
Obesity and Cancer Screening according to Race and Gender. J Obes (2011) 0.95
Public awareness of colorectal cancer screening: knowledge, attitudes, and interventions for increasing screening uptake. ISRN Oncol (2014) 0.95
Factors associated with participation in colorectal cancer screening in Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). Int J Colorectal Dis (2012) 0.95
Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer (2013) 0.95
A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer (2010) 0.93
Predictors of endoscopic colorectal cancer screening over time in 11 states. Cancer Causes Control (2009) 0.93
Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population. Rheumatol Int (2010) 0.92
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92
Mechanism of action and toxicities of purgatives used for colonoscopy preparation. Expert Opin Drug Metab Toxicol (2011) 0.92
Different effects of multiple health status indicators on breast and colorectal cancer screening in a nationally representative US sample. Cancer Epidemiol (2011) 0.91
New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies. Prev Chronic Dis (2004) 0.91
Giant inflatable colon and community knowledge, intention, and social support for colorectal cancer screening. Prev Chronic Dis (2013) 0.91
Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening. Colorectal Cancer (2014) 0.91
Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health (2010) 0.90
Correlates of colorectal cancer screening among residents of Ohio Appalachia. J Community Health (2013) 0.90
Predictors of colorectal cancer testing using the California Health Inventory Survey. World J Gastroenterol (2013) 0.90
Colorectal cancer knowledge is not associated with screening compliance or intention. J Cancer Educ (2009) 0.89
Colorectal cancer screening among primary care patients: does risk affect screening behavior? J Community Health (2011) 0.89
Get screened: a pragmatic randomized controlled trial to increase mammography and colorectal cancer screening in a large, safety net practice. BMC Health Serv Res (2010) 0.88
Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2012) 0.88
Alternative approaches to assessing intervention effectiveness in randomized trials: application in a colorectal cancer screening study. Cancer Causes Control (2011) 0.87
Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field. Cancer (2013) 0.87
Challenges to research in urban community health centers. Am J Public Health (2006) 0.87
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer (2003) 6.92
Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology (2004) 4.69
Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49
Use of SEER-Medicare data for measuring cancer surgery. Med Care (2002) 4.27
Studying radiation therapy using SEER-Medicare-linked data. Med Care (2002) 4.13
Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med (2012) 4.07
Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 3.64
Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care (2005) 3.53
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care (2002) 3.36
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology (2004) 3.22
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 3.05
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat (2012) 3.02
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst (2003) 2.99
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med (2013) 2.89
Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med (2009) 2.84
A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer (2007) 2.64
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol (2008) 2.62
Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev (2011) 2.62
Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med (2003) 2.56
In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care (2006) 2.53
Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care (2008) 2.48
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer (2004) 2.38
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer (2007) 2.30
Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev (2004) 2.26
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med (2003) 2.19
Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc (2006) 2.14
The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control (2009) 2.14
Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Am J Prev Med (2010) 2.12
Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care (2008) 2.11
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev (2007) 2.02
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
Health care provider surveys in the United States, 2000-2010: a review. Eval Health Prof (2013) 2.02
Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med (2008) 2.02
Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med (2008) 2.01
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med (2004) 1.97
Effectiveness of Cultivando la Salud: a breast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health (2009) 1.95
Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial. J Natl Cancer Inst (2008) 1.89
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Which women aren't getting mammograms and why? (United States). Cancer Causes Control (2007) 1.85
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Fam Med (2005) 1.81
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med (2011) 1.80
Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80
Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis (2006) 1.79
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.72
Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev (2008) 1.72
The case for cases: publishing high-quality case reports in Homeopathy. Homeopathy (2002) 1.72
National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst Monogr (2004) 1.70
Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med (2009) 1.68
The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med (2010) 1.68
Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev (2006) 1.65
Colorectal cancer screening among Latinos from U.S. cities along the Texas-Mexico border. Cancer Causes Control (2007) 1.64
Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol (2009) 1.64
Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med (2013) 1.62
Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting. Eur Urol (2006) 1.62
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer (2002) 1.62
Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen. Urology (2009) 1.62
Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med (2002) 1.61
Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med (2004) 1.60
Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol (2007) 1.58
Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health (2003) 1.57
Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv (2007) 1.56
Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health (2004) 1.55
Behind closed doors: physician-patient discussions about colorectal cancer screening. J Gen Intern Med (2009) 1.55
Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med (2004) 1.55
Complementary therapies and the NHS. BMJ (2005) 1.55
A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev (2003) 1.54
How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet (2003) 1.54
Correlates of repeat and recent mammography for women ages 45 to 75 in the 2002 to 2003 Health Information National Trends Survey (HINTS 2003). Cancer Epidemiol Biomarkers Prev (2006) 1.54
Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc (2007) 1.49
General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.47
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med (2010) 1.47
Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health (Larchmt) (2007) 1.45